NPC1L1 and obesity due to melanocortin 4 receptor deficiency: Interestingly, NPC1L1 is not only a relevant molecular target for hyperlipidemia therapy but also for obesity management, considering that the cholesterol uptake rate is known to be one of the main elevating factors of obesity.